BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mar AC, Chu CH, Lee HJ, Chien CW, Cheng JJ, Yang SH, Jiang JK, Lee TC. Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis. J Biol Chem 2015;290:22212-24. [PMID: 26209639 DOI: 10.1074/jbc.M115.644823] [Cited by in Crossref: 49] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu J, Li T, Du X, Wu Q, Le YZ. G protein-coupled receptor 91 signaling in diabetic retinopathy and hypoxic retinal diseases. Vision Res. 2017;139:59-64. [PMID: 28539261 DOI: 10.1016/j.visres.2017.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
2 Muhammad N, Bhattacharya S, Steele R, Phillips N, Ray RB. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2017;23:3120-8. [PMID: 27965308 DOI: 10.1158/1078-0432.CCR-16-2811] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]
3 Han D, Yang P, Qin B, Ji G, Wu Y, Yu L, Zhang H. Upregulation of Nogo-B by hypoxia inducible factor-1 and activator protein-1 in hepatocellular carcinoma. Cancer Sci 2021;112:2728-38. [PMID: 33963651 DOI: 10.1111/cas.14941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Bourassa P, Tremblay C, Schneider JA, Bennett DA, Calon F. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease. Acta Neuropathol 2019;137:801-23. [PMID: 30729296 DOI: 10.1007/s00401-019-01967-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
5 Mukwaya A, Peebo B, Xeroudaki M, Ali Z, Lennikov A, Jensen L, Lagali N. Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesis. Sci Rep 2016;6:32137. [PMID: 27561355 DOI: 10.1038/srep32137] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
6 Broholm M, Degett TH, Furbo S, Fiehn AK, Bulut M, Litman T, Eriksen JO, Troelsen JT, Gjerdrum LMR, Gögenur I. Colonic Stent as Bridge to Surgery for Malignant Obstruction Induces Gene Expressional Changes Associated with a More Aggressive Tumor Phenotype. Ann Surg Oncol 2021;28:8519-31. [PMID: 34467497 DOI: 10.1245/s10434-021-10226-4] [Reference Citation Analysis]
7 Li T, Hu J, Gao F, Du X, Chen Y, Wu Q. Transcription factors regulate GPR91-mediated expression of VEGF in hypoxia-induced retinopathy. Sci Rep 2017;7:45807. [PMID: 28374767 DOI: 10.1038/srep45807] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
8 Subramaniam S, Selvaduray KR, Radhakrishnan AK. Bioactive Compounds: Natural Defense Against Cancer? Biomolecules 2019;9:E758. [PMID: 31766399 DOI: 10.3390/biom9120758] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
9 Jia J, Ye T, Cui P, Hua Q, Zeng H, Zhao D. AP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation. Microvasc Res 2016;105:103-8. [PMID: 26860974 DOI: 10.1016/j.mvr.2016.02.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
10 Kumar R, Mani AM, Singh NK, Rao GN. PKCθ-JunB axis via upregulation of VEGFR3 expression mediates hypoxia-induced pathological retinal neovascularization. Cell Death Dis 2020;11:325. [PMID: 32382040 DOI: 10.1038/s41419-020-2522-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Li J, Huang L, Zhao H, Yan Y, Lu J. The Role of Interleukins in Colorectal Cancer.Int J Biol Sci. 2020;16:2323-2339. [PMID: 32760201 DOI: 10.7150/ijbs.46651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zhang L, Qiang J, Yang X, Wang D, Rehman AU, He X, Chen W, Sheng D, Zhou L, Jiang YZ, Li T, Du Y, Feng J, Hu X, Zhang J, Hu XC, Shao ZM, Liu S. IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 Stability. Adv Sci (Weinh) 2020;7:1901728. [PMID: 31921558 DOI: 10.1002/advs.201901728] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
13 Ouyang W, Ren L, Liu G, Chi X, Wei H. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer. PeerJ 2019;7:e6683. [PMID: 30972258 DOI: 10.7717/peerj.6683] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
14 Schlüter T, Schelmbauer C, Karram K, Mufazalov IA. Regulation of IL-1 signaling by the decoy receptor IL-1R2. J Mol Med (Berl) 2018;96:983-92. [PMID: 30109367 DOI: 10.1007/s00109-018-1684-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mao R, Yang F, Wang Z, Xu C, Liu Q, Liu Y, Zhang T. Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma. Front Cell Dev Biol 2021;9:625212. [PMID: 33732694 DOI: 10.3389/fcell.2021.625212] [Reference Citation Analysis]
16 Ye YP, Wu P, Gu CC, Deng DL, Jiao HL, Li TT, Wang SY, Wang YX, Xiao ZY, Wei WT, Chen YR, Qiu JF, Yang RW, Lin J, Liang L, Liao WT, Ding YQ. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression. Oncotarget 2016;7:61312-24. [PMID: 27494869 DOI: 10.18632/oncotarget.11016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
17 Nguyen XX, Nishimoto T, Takihara T, Mlakar L, Bradshaw AD, Feghali-Bostwick C. Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis. Am J Physiol Lung Cell Mol Physiol 2021;320:L29-40. [PMID: 33026236 DOI: 10.1152/ajplung.00173.2020] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Chang S, Jain V, Chen T, Patel AS, Pidugu HB, Lin Y, Wu M, Huang J, Wu H, Shah A, Su T, Lee T. Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1- a ]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links. J Med Chem 2019;62:2404-18. [DOI: 10.1021/acs.jmedchem.8b01689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
19 Li G, Hu X, Sun L, Li X, Li J, Li T, Zhang X. C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance. Cell Mol Biol Lett 2018;23:6. [PMID: 29483928 DOI: 10.1186/s11658-017-0067-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Zhu Q, Chen J, Pan P, Lin F, Zhang X. UBE2N Regulates Paclitaxel Sensitivity of Ovarian Cancer via Fos/P53 Axis. Onco Targets Ther 2020;13:12751-61. [PMID: 33363381 DOI: 10.2147/OTT.S271164] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Cao D, Xu N, Chen Y, Zhang H, Li Y, Yuan Z. Construction of a Pearson- and MIC-Based Co-expression Network to Identify Potential Cancer Genes. Interdiscip Sci 2021. [PMID: 34694561 DOI: 10.1007/s12539-021-00485-w] [Reference Citation Analysis]
22 Matsusaka S, Hanna DL, Cao S, Zhang W, Yang D, Ning Y, Sunakawa Y, Okazaki S, Berger MD, Miyamato Y, Parekh A, Stintzing S, Loupakis F, Lenz HJ. Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Clin Cancer Res 2016;22:3218-26. [PMID: 26839145 DOI: 10.1158/1078-0432.CCR-15-2422] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
23 Liu J, Yang Y, Li H, Liu Y, Sun Y, Wu J, Xiong Z, Jin T. IL1R2 Polymorphisms are Associated with Increased Risk of Esophageal Cancer. Curr Mol Med 2020;20:379-87. [PMID: 31744444 DOI: 10.2174/1566524019666191025091204] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Hu JW, Ding GY, Fu PY, Tang WG, Sun QM, Zhu XD, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis. Biomed Res Int 2020;2020:6784138. [PMID: 32280695 DOI: 10.1155/2020/6784138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Xu Z, Zhu C, Chen C, Zong Y, Feng H, Liu D, Feng W, Zhao J, Lu A. CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer. Cell Death Dis 2018;9:974. [PMID: 30250188 DOI: 10.1038/s41419-018-1010-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
26 Goulart MR, Hlavaty SI, Chang YM, Polton G, Stell A, Perry J, Wu Y, Sharma E, Broxholme J, Lee AC, Szladovits B, Turmaine M, Gribben J, Xia D, Garden OA. Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells. Sci Rep 2019;9:3574. [PMID: 30837603 DOI: 10.1038/s41598-019-40285-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
27 Song Z, Lin Y, Ye X, Feng C, Lu Y, Yang G, Dong C. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer. Med Sci Monit 2016;22:4475-81. [PMID: 27866212 DOI: 10.12659/msm.898569] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
28 Espinosa-Cotton M, Rodman Iii SN, Ross KA, Jensen IJ, Sangodeyi-Miller K, McLaren AJ, Dahl RA, Gibson-Corley KN, Koch AT, Fu YX, Badovinac VP, Laux D, Narasimhan B, Simons AL. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma. J Immunother Cancer 2019;7:79. [PMID: 30890189 DOI: 10.1186/s40425-019-0550-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
29 Munguía-Moreno JA, Díaz-Chavéz J, García-Villa E, Albino-Sanchez ME, Mendoza-Villanueva D, Ocadiz-Delgado R, Bonilla-Delgado J, Marín-Flores A, Cortés-Malagón EM, Alvarez-Rios E, Hidalgo-Miranda A, Üren A, Çelik H, Lambert PF, Gariglio P. Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model. Int J Oncol 2018;53:579-91. [PMID: 29901186 DOI: 10.3892/ijo.2018.4432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Yuan M, Wang L, Huang H, Li Y, Zheng X, Shao Q, Jiang J. IL-1R2 expression in human gastric cancer and its clinical significance. Biosci Rep 2021;41:BSR20204425. [PMID: 33704402 DOI: 10.1042/BSR20204425] [Reference Citation Analysis]